Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action

• Published in: Biochimica et biophysica acta Vol. 1790; no. 5; pp. 283 - 308
• Main Authors: Mayer, Alejandro M.S., Rodríguez, Abimael D., Berlinck, Roberto G.S., Hamann, Mark T.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.05.2009
• Subjects: Amino Acid Sequence; Animals; Anti-Infective Agents - chemistry; Anti-Infective Agents - pharmacology; Biological Products - chemistry; Biological Products - pharmacology; Cardiovascular System - drug effects; Drug; Humans; Immune System - drug effects; Marine; Marine Biology; Metabolite; Molecular Sequence Data; Natural product; Nervous System - drug effects; Pharmacology; Review; Toxicology; Drug; Toxicology; Marine; Metabolite; Natural product; Pharmacology; Review
• ISSN: 0304-4165; 0006-3002; 1872-8006
• DOI: 10.1016/j.bbagen.2009.03.011

The review presents the 2005–2006 peer-reviewed marine pharmacology literature, and follows a similar format to the authors' 1998–2004 reviews. The preclinical pharmacology of chemically characterized marine compounds isolated from marine animals, algae, fungi and bacteria is systematically presented. Anthelmintic, antibacterial, anticoagulant, antifungal, antimalarial, antiprotozoal, antituberculosis and antiviral activities were reported for 78 marine chemicals. Additionally 47 marine compounds were reported to affect the cardiovascular, immune and nervous system as well as possess anti-inflammatory effects. Finally, 58 marine compounds were shown to bind to a variety of molecular targets, and thus could potentially contribute to several pharmacological classes. Marine pharmacology research during 2005–2006 was truly global in nature, involving investigators from 32 countries, and the United States, and contributed 183 marine chemical leads to the research pipeline aimed at the discovery of novel therapeutic agents. Continued preclinical and clinical research with marine natural products demonstrating a broad spectrum of pharmacological activity will probably result in novel therapeutic agents for the treatment of multiple disease categories.